File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.ijrobp.2015.06.006
- Scopus: eid_2-s2.0-84941316661
- PMID: 26279324
- WOS: WOS:000361250100021
- Find via
Supplementary
- Citations:
- Appears in Collections:
Conference Paper: Adverse outcomes after palliative radiation therapy for uncomplicated spine metastases: Role of spinal instability and single-fraction radiation therapy
Title | Adverse outcomes after palliative radiation therapy for uncomplicated spine metastases: Role of spinal instability and single-fraction radiation therapy |
---|---|
Authors | |
Issue Date | 2015 |
Citation | Annual Meeting of the American Society for Radiation Oncology, San Francisco, CA, 14-17 September 2014. In International Journal of Radiation Oncology - Biology - Physics, 2015, v. 93, n. 2, p. 373-381 How to Cite? |
Abstract | © 2015 Elsevier Inc. All rights reserved. Purpose Level I evidence demonstrates equivalent pain response after single-fraction (SF) or multifraction (MF) radiation therapy (RT) for bone metastases. The purpose of this study is to provide additional data to inform the incidence and predictors of adverse outcomes after RT for spine metastases. Methods and Materials At a single institution, 299 uncomplicated spine metastases (without cord compression, prior RT, or surgery) treated with RT from 2008 to 2013 were retrospectively reviewed. The spinal instability neoplastic score (SINS) was used to assess spinal instability. The primary outcome was time to first spinal adverse event (SAE) at the site, including symptomatic vertebral fracture, hospitalization for site-related pain, salvage surgery, interventional procedure, new neurologic symptoms, or cord compression. Fine and Gray's multivariable model assessed associations of the primary outcome with SINS, SF RT, and other significant baseline factors. Propensity score matched analysis further assessed the relationship of SF RT to first SAEs. Results The cumulative incidence of first SAE after SF RT (n=66) was 6.8% at 30 days, 16.9% at 90 days, and 23.6% at 180 days. For MF RT (n=233), the incidence was 3.5%, 6.4%, and 9.2%, respectively. In multivariable analysis, SF RT (hazard ratio [HR] = 2.8, 95% confidence interval [CI] 1.5-5.2, P=.001) and SINS ≥11 (HR=2.5, 95% CI 1.3-4.9, P=.007) were predictors of the incidence of first SAE. In propensity score matched analysis, first SAEs had developed in 22% of patients with SF RT versus 6% of those with MF RT cases (HR=3.9, 95% CI 1.6-9.6, P=.003) at 90 days after RT. Conclusion In uncomplicated spinal metastases treated with RT alone, spinal instability with SINS ≥11 and SF RT were associated with a higher rate of SAEs. |
Persistent Identifier | http://hdl.handle.net/10722/223112 |
ISSN | 2023 Impact Factor: 6.4 2023 SCImago Journal Rankings: 1.992 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lam, Tai Chung | - |
dc.contributor.author | Uno, Hajime | - |
dc.contributor.author | Krishnan, Monica | - |
dc.contributor.author | Lutz, Steven | - |
dc.contributor.author | Groff, Michael | - |
dc.contributor.author | Cheney, Matthew | - |
dc.contributor.author | Balboni, Tracy | - |
dc.date.accessioned | 2016-02-19T02:37:46Z | - |
dc.date.available | 2016-02-19T02:37:46Z | - |
dc.date.issued | 2015 | - |
dc.identifier.citation | Annual Meeting of the American Society for Radiation Oncology, San Francisco, CA, 14-17 September 2014. In International Journal of Radiation Oncology - Biology - Physics, 2015, v. 93, n. 2, p. 373-381 | - |
dc.identifier.issn | 0360-3016 | - |
dc.identifier.uri | http://hdl.handle.net/10722/223112 | - |
dc.description.abstract | © 2015 Elsevier Inc. All rights reserved. Purpose Level I evidence demonstrates equivalent pain response after single-fraction (SF) or multifraction (MF) radiation therapy (RT) for bone metastases. The purpose of this study is to provide additional data to inform the incidence and predictors of adverse outcomes after RT for spine metastases. Methods and Materials At a single institution, 299 uncomplicated spine metastases (without cord compression, prior RT, or surgery) treated with RT from 2008 to 2013 were retrospectively reviewed. The spinal instability neoplastic score (SINS) was used to assess spinal instability. The primary outcome was time to first spinal adverse event (SAE) at the site, including symptomatic vertebral fracture, hospitalization for site-related pain, salvage surgery, interventional procedure, new neurologic symptoms, or cord compression. Fine and Gray's multivariable model assessed associations of the primary outcome with SINS, SF RT, and other significant baseline factors. Propensity score matched analysis further assessed the relationship of SF RT to first SAEs. Results The cumulative incidence of first SAE after SF RT (n=66) was 6.8% at 30 days, 16.9% at 90 days, and 23.6% at 180 days. For MF RT (n=233), the incidence was 3.5%, 6.4%, and 9.2%, respectively. In multivariable analysis, SF RT (hazard ratio [HR] = 2.8, 95% confidence interval [CI] 1.5-5.2, P=.001) and SINS ≥11 (HR=2.5, 95% CI 1.3-4.9, P=.007) were predictors of the incidence of first SAE. In propensity score matched analysis, first SAEs had developed in 22% of patients with SF RT versus 6% of those with MF RT cases (HR=3.9, 95% CI 1.6-9.6, P=.003) at 90 days after RT. Conclusion In uncomplicated spinal metastases treated with RT alone, spinal instability with SINS ≥11 and SF RT were associated with a higher rate of SAEs. | - |
dc.language | eng | - |
dc.relation.ispartof | International Journal of Radiation Oncology - Biology - Physics | - |
dc.title | Adverse outcomes after palliative radiation therapy for uncomplicated spine metastases: Role of spinal instability and single-fraction radiation therapy | - |
dc.type | Conference_Paper | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1016/j.ijrobp.2015.06.006 | - |
dc.identifier.pmid | 26279324 | - |
dc.identifier.scopus | eid_2-s2.0-84941316661 | - |
dc.identifier.hkuros | 272306 | - |
dc.identifier.volume | 93 | - |
dc.identifier.issue | 2 | - |
dc.identifier.spage | 373 | - |
dc.identifier.epage | 381 | - |
dc.identifier.eissn | 1879-355X | - |
dc.identifier.isi | WOS:000361250100021 | - |
dc.identifier.issnl | 0360-3016 | - |